Datamonitor

News Datamonitor

• Santhera Announces Intent To File Marketing Authorization Application for Leber's Hereditary Optic Neuropathy

  Santhera Pharmaceuticals announced that it has formally notified the European Medicines Agency of its intent to file for Leber's Hereditary Optic Neuropathy (LHON). In the recent RHODOS study, Catena® showed consistent superiority over placebo and, in particular, improved or protected visual acuity more

• KAEL-GemVax reports significant interim progress in UK TeloVac Phase III study of anti-telomerase vaccine in pancreatic cancer

  KAEL-GemVax announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major “blockbuster” potential as a universal t more

• Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018

  The Australian oncology market’s high value and growth opportunities have made it an attractive arena for drug developers to enter. Top 20 cancer therapy brands sales totaled $545m in Australia in 2008, growing at a CAGR of 30% since 2005. Although this growth is expected to slow down considerably d more

Publications Datamonitor

• Prematurely ended phase III trials in Sweden during the years 2002–2008

  Purpose The aim of this study was to identify prematurely ended phase III clinical trials (CTs) and the proportion of such trials among all phase III CTs, review the reasons for the premature discontinuation of the CT, determine whether a data monitoring committee (DMC) was involved in this decision more

• Improving the quality of drug research or simply increasing its cost? An evidence‐based study of the cost for data monitoring in clinical trials

  WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Current knowledge is based on practical experience. This paper presents the first novel, quantitative and qualitative view on the efficacy of the sponsor query system widely applied in the pharmaceutical industry, used for quality control purposes by more

• “One Teabag Is Better than Four”: Participants Response to the Discontinuation of 2% PRO2000/5 Microbicide Gel in KwaZulu-Natal, South Africa

  Introduction The Microbicides Development Programme evaluated the safety and effectiveness of 0.5% and 2% PRO2000/5 microbicide gels in reducing the risk of vaginally acquired HIV. In February 2008 the Independent Data Monitoring Committee recommended that evaluation of 2% PRO2000/5 gel be discont more

Market studies Datamonitor

• Global Leisure Products

  Introduction Global Leisure Products industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and anal more

• Global Leisure Facilities

  Introduction Global Leisure Facilities industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 5). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pr more

• Epidemiology: Major Abdominal Surgery – A key risk factor for deep vein thrombosis and pulmonary embolism

  Introduction In 2010, Datamonitor estimates that there were 7.4 million major abdominal surgeries in the seven major markets. This number is not expected to change significantly, growing to 8.1 million surgeries in 2020. Features and benefits * Gain insight to market potential, including a robust more

Websites Datamonitor